Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substitution of Ethambutol With Linezolid During the Intensive Phase of Treatment of Pulmonary Tuberculosis: A Prospective, Multicenter, Randomized, Open-label Phase II Trial

NCT01994460 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01994460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01994460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substitution of Ethambutol With Linezolid During the Intensive Phase of Treatment of Pulmonary Tuberculosis: A Prospective, Multicenter, Randomized, Open-label Phase II Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2014
Completion date
June 30, 2016
Enrollment
429 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary tuberculosis without resistance to rifampicin